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Abstract
Purpose—To describe and characterize a novel observation of intraluminal deposits of glaucoma 
tube shunts (TS) using spectral domain (SD) ocular coherence topography (OCT).
Patients and Methods—Fifteen TS in 11 patients diagnosed with primary open angle, 
neovascular, aphakic, and uveitic glaucomas. Both Ahmed (n = 11) and Baerveldt (n = 4) TS were 
examined with 5-line raster anterior segment SD-OCT imaging.
Results—The exposed tubes of two patients had highly reflective intraluminal deposits in the 
corresponding exposed areas. Seven tubes without exposure had a thin rim of highly reflective 
material. Six tubes were clear of luminal deposits. The most common diagnosis in the study was 
uveitic glaucoma which occurred in 5 of the 15 eyes (33%). The next most common diagnosis was 
primary open angle glaucoma which occurred in 4 of the 15 eyes (25%). There were 2 non-valved 
Baerveldt tubes in each group. The mean duration of tube shunt implantation was 15.0 months in 
the deposit group and 33.7 months in the group without luminal deposits. The majority of patients 
in each group were using eye drops at presentation (88.9% deposit, 83.3% clear), and the average 
intraocular pressure was 20.2 mmHg in the deposit group and 19.0 mmHg in the clear group.
Conclusions—Anterior segment OCT imaging may be used to evaluate TS integrity. 
Intraluminal deposits in tube shunts may occur as a natural response to implanted drainage device, 
possibly as an inflammatory response.
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INTRODUCTION
A leading cause of blindness in the world, glaucoma is a heterogeneous disease that causes 
irreversible damage to the optic nerve. Lowering intraocular pressure remains to be the only 
proven therapy. [1] Aqueous drainage tube shunts were created as an alternative means from 
the standard trabeculectomy approach to divert extra-ocular fluid. There are four main 
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shunts utilized in the US: Baerveldt® (Advanced Medical Optics, Inc., Santa Ana, CA, 
USA), Ahmed™ (New World Medical Inc., Rancho Cucamunga, CA, USA), Molteno® 
(Molteno Ophthalmic Ltd., Dunedin New Zealand), and Krupin (Eagle Vision, Inc., 
Memphis, TN, USA). [2–3] They contain silicone tubes with an internal diameter of 
approximately 300 μm, which can be inserted into the anterior chamber or vitreous cavity (in 
vitrectomized eyes) and are connected to an equatorial plate varying in surface area 
depending on the model. The equatorial plate is surrounded by a fibrovascular capsule which 
contain capillaries that will drain the shunted ocular fluid. The ideal tube shunts would 
improve aqueous outflow with minimal complications. [2] Complications documented are 
hypotony, choroidal effusion, shallow or flat anterior chamber, corneal decompensation, 
diplopia, tube obstructions, tube erosion, and increased intraocular pressure. [4] Despite the 
complications, tube shunts are becoming the first-line surgical option in glaucoma, 
researched by the randomized, prospective Tube versus Trabeculectomy (TVT) study. [5] 
Anterior segment SD-OCT has recently been introduced in glaucoma evaluation. This 
imaging modality is a non-contact, non-invasive method to evaluate the anterior chamber 
(AC) and is usually used to examine AC depth, cornea, iris, and lens. In glaucoma, anterior 
segment OCT has been used to evaluate scleral flaps, trabeculectomy blebs, and patent laser 
iridotomies [6]. Tube shunts buried under tutoplast and/or conjunctiva and coursing into the 
AC are typically limited to slit lamp examination or a more invasive method. Anterior 
segment OCT has only been used to determine tube shunt position and patency [7]. This 
study presents novel findings of intraluminal deposits of tube shunts via anterior segment 
OCT imaging.
MATERIALS AND METHODS
This was a IRB-approved retrospective chart review conducted during spring 2014, 
involving 11 patients and 15 eyes of patients diagnosed with glaucoma who had received a 
tube shunt (Ahmed (AGV; New World Medical, Ranchos Cucamonga, CA)) or (BGI; Abbott 
Medical Optics, Abbott Park, IL) [8] in one or both eyes. Patients had received their eye care 
and OCT imaging at Sydney and Lois Eskenazi Eye Clinic in Indianapolis, IN. Glaucoma 
diagnoses included primary open angle glaucoma, chronic angle closure, aphakic glaucoma, 
uveitic glaucoma, or neovascular glaucoma. In addition, patients were older than 18 years 
old, with either Ahmed or Baerveldt tube shunt implantations and light perception or better 
visual acuity. Patients excluded from the study were younger than 18 years old with no light 
perception vision, and who had undergone previous retinal surgery with silicone oil. Each 
patient underwent eye examination, including visual acuity using standard distance Snellen 
chart, applanation tonometry, and slit lamp examination of anterior segment, including the 
tube shunt. Additionally, patients underwent imaging with the Carl Zeiss spectral domain 5-
line raster HD-OCT of the anterior segment concentrating on the tube beneath the 
conjunctiva or tutoplast. Patient’s demographic data was collected and analyzed using 
Microsoft Excel 2002, and the standard Chi test was utilized to obtain p-values via Excel.
RESULTS
Of 11 patients with tube shunts, 6 presented with intraluminal deposits, 4 with no deposits, 
and 1 had deposits in one eye but not in the other. The age of the patients ranged from 41–
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83. The range for the deposit group was 41–78 with a mean age of 60.4 years old, and the 
clear group ranged from 41–83 with a mean of 58.6 years old. Both groups were split fairly 
evenly between genders, with 3 eyes from males in both groups (42.8% deposit, 60% clear) 
and 4 eyes from females (57.1%) in the deposit tube group and 2 (40%) in the clear tube 
group. Both groups were comprised of predominantly African-Americans with only 1 
Hispanic American in the deposit group (14.3%).
The 2 eyes with exposed tube shunts exhibited intraluminal deposits on the exposed area, 
while 7 of 13 eyes without exposure had a thin rim of highly reflective material. The most 
common diagnosis in the study was uveitic glaucoma, which occurred in 5 of the 15 eyes (3 
deposit, 2 clear). The next most common diagnosis was both primary open angle and 
neovascular glaucoma (NVG), which occurred in 4 of the 15 eyes, respectively (1 deposit, 3 
clear; 4 deposit, 0 clear). The predominant tube represented in the study was the valved 
Ahmed tube with 11 of the 15 eyes (7 deposit, 4 clear). There were 2 non-valved Baerveldt 
tubes in each group. The mean duration of tube shunt implantation was 15.0 months in the 
deposit group and 33.7 in the clear tube group. The majority of patients in each group were 
using eye drops at presentation (88.9% deposit, 83.3% clear), and the average intraocular 
pressure was 20.2 mmHg in the deposit group and 19.0 mmHg in the clear group.
DISCUSSION
In this study, we are first to report a novel intraluminal deposit in the TS of glaucoma 
drainage devices using AS-OCT. The two most common aqueous tube shunts examined in 
the present study are the Ahmed valve and the Baerveldt implant. Once the tube shunt is in 
place, the slit lamp is the primary means to examine the tube shunt apparatus by verifying 
presence of bleb, position of tube in anterior chamber or sulcus, and tube coverage with 
conjunctiva. For instance, a 78-year-old female with uveitic glaucoma who presented with 
approximately 5 mm of Ahmed tube shunt exposure exhibited unique, white crystalline 
deposits as depicted in slit lamp photos (Figure 1A). However, there remains no non-
invasive way to investigate the tube. This study utilized SD-OCT of the anterior segment to 
investigate the intraluminal aspect of tube shunts. In previous studies, anterior segment OCT 
has been used to evaluate the position and patency of tube shunts, but no similar study has 
been conducted thus far [7]. In this case, SD-OCT confirmed the presence of reflective 
deposits on the inner aspect (Figure 1B).
The majority of demographic data between the two groups were similar, such as mean age 
and gender composition, with African-Americans as the predominant race (10/11 patients, 
90.9%). In terms of diagnosis and treatment, both groups had a majority of Ahmed tube 
shunts with only 2 Baerveldts in each group. Similarly, the intraocular pressure was 
comparable between the two groups (20.2 mmHg vs 19 mmHg, see table 1), and the 
majority of patients in both groups were on eye drops.
The main difference between the deposit group and the clear tube group was glaucoma 
diagnosis, with the common diagnosis being NVG (4 deposit, 0 clear) and primary open 
angle glaucoma (1 deposit, 3 clear). However, due to the small sample size, this difference 
was not statistically significant (p-value=0.22, 0.19, see Table 1). NVG is characterized by 
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the breakdown of the blood-aqueous barrier [9], and all patients with NVG in this study 
exhibited intraluminal deposits. Proteomic studies show inflammatory markers in aqueous 
humor of patients after tube shunt surgery, suggesting the inserted tubes cause a breach in 
the blood-aqueous barrier and produce an influx of inflammatory proteins [10]. Deposits 
may be expected in such cases. Therefore, blood-aqueous barrier breach may be associated 
with the build-up of these deposits.
Although the intraluminal deposits can be seen, the composition of the material is still 
unclear. Initially, the patient referred to in Figure 1 was managed on topical antibiotics, but 
when the exposure did not heal, she was scheduled for tube shunt removal and reinsertion 
with a tube extender. The extracted tube (Figure 1C) was sent for microbiological analysis 
with chemical staining, but due to the fragile nature of the tube and cellular material, the 
results were inconclusive. The leading thoughts on the material are calcification based on the 
slit lamp appearance of patient 1, who had the largest, most visible deposits. Intraluminal 
calcium deposits would be consistent with the highly reflective appearance on OCT imaging. 
Similar hyper-reflective OCT findings have been documented in other disease processes 
involving calcium deposits, such as idiopathic sclerochoroidal calcification, macular drusen, 
and calcified intraocular lenses. [11–13].
We discovered that tube shunt deposits are present both in exposed tubes (2 of 2 eyes) and in 
cases where no exposure occurred (7 of 13 eyes). Interestingly, two months after a new, 
unexposed tube was implanted in the patient from Figure 1, intraluminal deposits developed 
again (Figure 1D). Taken together, these findings indicate that deposits are a more general 
occurrence in tube shunts irrespective of exposure. Additionally, after careful review of AS-
OCT images of patients with deposits, it was apparent that overlying conjunctival vascularity 
and tutoplast thickness, or lack thereof, did not play a role in the prevalence of intraluminal 
deposits. For instance, OCT imaging depicts patients with exposure and, therefore, no 
conjunctiva or tutoplast overlying the tube with deposits (Figure 1B). However, similar 
deposits can be seen in patients with unexposed tube shunts who have tutoplast and 
conjunctiva in place (Figure 1E). Moreover, intraluminal deposits can be seen in the same 
patient depicted in Figure 1B after reinsertion of a new, unexposed tube shunt, showing a 
quite vascular conjunctiva and thick tutoplast overlying the tube (Figure 1D).
Tube shunts are becoming more commonly used as initial surgical treatment of glaucoma [8, 
14]. With the development of newer technology, such as SD-OCT with higher speed and 
scan depth, there are now additional avenues for tube shunt examination in glaucoma. [15–
16]. This study demonstrates a novel, non-invasive means to examine the lumen of tubes 
using OCT imaging. However, the limitations of this study are its retrospective nature, small 
sample size, and that patients come from an urban, tertiary eye care center, in addition to the 
homogeneity of the racial demographics and underrepresentation of Baerveldt tubes. Future 
directions of this study include obtaining more patients and following the tubes long-term to 
track deposit development; using a non-invasive procedure such as OCT imaging as shown 
in this study would be ideal for examining the lumen of tubes. Further investigation is 
required to elucidate the implications of these intraluminal deposits, in particular, identifying 
the composition of the deposits, the potentially inflammatory effect on patients, and the 
ultimate implications on surgical efficacy.
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(A) Intraluminal deposits in 5mm exposed tube shunt as depicted in the slit lamp photos. (B) 
Deposits were determined to be intraluminal by anterior segment SD-OCT. (C) Excised tube 
shunt was examined to contain crystalline deposits. (D) Transverse cross-sectional image of 
new, non-exposed tube shunt showing recurrence of intraluminal deposits. (E–F) OCT 
imaging of unexposed tube shunts depicting deposits around the rim (E) or no deposits (F).
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Table 1
Patient demographics. TS- tube shunt. POAG- primary open angle glaucoma. CACG- chronic angle closure 
glaucoma. NVG- neovascular glaucoma. AC- anterior chamber. IOP (intraocular pressure) was obtained via 
applanation.
Tubes with Deposits Tubes w/o Deposits
Patients 7 5
Demographics
Age (years old) 41–78 41–83
 Mean 60.4 58.6
 SD 14.55 15.5
Sex
 Male 3 42.80% 3 60%
 Female 4 57.10% 2 40%
Race
 African American 6 85.70% 5 100%
 Hispanic 1 14.30% 0 0%
Eyes 9 6
Diagnosis
 POAG 1 11.10% 3 50%
 CACG 1 11.10% 0 0%
 NVG 4 44.40% 0 0%
 Aphakic 0 0.00% 1 16.70%
 Uveitic 3 33.30% 2 33.30%
p-value 0.19 0.22
Duration of TS
 Mean (mons) 15 33.7
 SD 14.9 34.9
TS Type
 Ahmed 7 77.80% 4 66.70%
 Baeveldt 2 22.20% 2 33.30%
p-value 0.09 0.41
Using drops 8 88.90% 5 83.30%
AC Inflammation 2 22.20% 3 50%
Intraocular Pressure
 Mean 20.2 19
 SD 4.18 6.24
Exposure 2 22.20% 0 0.00%
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